Novartis opens up a path of research to protect proteins that guard against cancer.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

How much do you know about eyes? Learn more about the fastest muscle in the human body.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.